• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发性甲状旁腺功能亢进患者全甲状旁腺切除术后血清磷降低预测模型的构建与验证

Construction and validation of a predictive model for the serum phosphorus reduction after total parathyroidectomy in patients with secondary hyperparathyroidism.

作者信息

Feng Yingnan, Zhou Yinghui, Feng Xiaodong, Sa Qila, Zhang Ningyuan, Xie Wantao, Liu Bailiang, Chen Fengyang, Cheng Guangming, Zhang Wei

机构信息

Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command, Shenyang, China.

Postgraduate College, Dalian Medical University, Dalian, China.

出版信息

Front Endocrinol (Lausanne). 2025 May 29;16:1584602. doi: 10.3389/fendo.2025.1584602. eCollection 2025.

DOI:10.3389/fendo.2025.1584602
PMID:40510469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12158720/
Abstract

OBJECTIVE

We aimed to construct a predictive scoring model for the factors influencing serum phosphorus reduction following total parathyroidectomy (tPTX) in secondary hyperparathyroidism (SHPT) and provide a reference for identifying patients who can successfully correct hyperphosphatemia before surgery.

METHODS

The clinical data of 529 patients with SHPT who underwent tPTX were retrospectively analyzed according to the inclusion and exclusion criteria. Univariate and multivariate analyses were conducted to determine the independent factors and establish a predictive scoring model. The receiver operating characteristic curve (ROC) was applied to verify the model in the training and validation groups, respectively.

RESULTS

In the whole group, 315 patients had a significant decrease in serum phosphorus after tPTX. Univariate and multivariate analysis showed that preoperative alkaline phosphatase (AKP), intact parathyroid hormone (iPTH) and free triiodothyronine (FT3) were independent influencing factors to promote the decrease of serum phosphorus after tPTX; Serum phosphorus and bone pain were inhibitory factors (all P<0.05). According to the cut-off value, AKP>193.33 U/L, iPTH>1808 pg/mL, FT3>2.825 pg/mL, serum phosphorus>2.285 mmol/L and bone pain were used to establish the predictive scoring model for serum phosphorus decline. The results showed that the success rate of serum phosphorus reduction was 67.55% at 1014 points and 95.35% at 1524 points. The area under ROC curves (AUC) for the training and validation group were 0.818 (95% CI=0.7750.861) and 0.840 (95% CI=0.7800.901, both P<0.05).

CONCLUSION

The established prediction score model for serum phosphorus decrease has a good prediction efficiency which is helpful for the early identification. The model provides important clinical guidance for the postoperative management and treatment of SHPT.

摘要

目的

构建继发性甲状旁腺功能亢进症(SHPT)患者行甲状旁腺全切术(tPTX)后影响血清磷降低因素的预测评分模型,为术前识别能成功纠正高磷血症的患者提供参考。

方法

根据纳入和排除标准,回顾性分析529例行tPTX的SHPT患者的临床资料。进行单因素和多因素分析以确定独立因素并建立预测评分模型。分别应用受试者工作特征曲线(ROC)在训练组和验证组中验证该模型。

结果

全组中,315例患者tPTX后血清磷显著降低。单因素和多因素分析显示,术前碱性磷酸酶(AKP)、全段甲状旁腺激素(iPTH)和游离三碘甲状腺原氨酸(FT3)是促进tPTX后血清磷降低的独立影响因素;血清磷和骨痛是抑制因素(均P<0.05)。根据截断值,AKP>193.33 U/L、iPTH>1808 pg/mL、FT3>2.825 pg/mL、血清磷>2.285 mmol/L和骨痛用于建立血清磷下降的预测评分模型。结果显示,1014分血清磷降低成功率为67.55%,1524分成功率为95.35%。训练组和验证组的ROC曲线下面积(AUC)分别为0.818(95%CI=0.7750.861)和0.840(95%CI=0.7800.901,均P<0.05)。

结论

建立的血清磷降低预测评分模型具有良好的预测效能,有助于早期识别。该模型为SHPT的术后管理和治疗提供了重要的临床指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ffc/12158720/dc02a9700e90/fendo-16-1584602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ffc/12158720/e425d2d7e95a/fendo-16-1584602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ffc/12158720/dc02a9700e90/fendo-16-1584602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ffc/12158720/e425d2d7e95a/fendo-16-1584602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ffc/12158720/dc02a9700e90/fendo-16-1584602-g002.jpg

相似文献

1
Construction and validation of a predictive model for the serum phosphorus reduction after total parathyroidectomy in patients with secondary hyperparathyroidism.继发性甲状旁腺功能亢进患者全甲状旁腺切除术后血清磷降低预测模型的构建与验证
Front Endocrinol (Lausanne). 2025 May 29;16:1584602. doi: 10.3389/fendo.2025.1584602. eCollection 2025.
2
Evaluation of Long-Term Effects of Parathyroidectomy in Patients With Refractory Secondary Hyperparathyroidism.甲状旁腺切除术对难治性继发性甲状旁腺功能亢进患者的长期疗效评估。
Hemodial Int. 2025 Jul;29(3):354-362. doi: 10.1111/hdi.13222. Epub 2025 Apr 4.
3
To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for Secondary Hyperparathyroidism in chronic renal failure: A Systematic Review and Meta-Analysis.评估甲状旁腺切除术(TPTX 与 TPTX+AT)治疗慢性肾衰竭继发甲状旁腺功能亢进的效果:系统评价和荟萃分析。
Int J Surg. 2017 Aug;44:353-362. doi: 10.1016/j.ijsu.2017.06.029. Epub 2017 Jun 17.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial.在一项随机试验中,辅助使用活性维生素D会降低非透析慢性肾脏病患者使用缓释骨化二醇治疗继发性甲状旁腺功能亢进期间的肾功能。
Am J Nephrol. 2025;56(4):490-499. doi: 10.1159/000544086. Epub 2025 Feb 21.
6
Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: systematic review and meta-analysis.甲状旁腺全切除术与甲状旁腺全切除加自体移植治疗继发性甲状旁腺功能亢进症的比较:系统评价和荟萃分析。
Ren Fail. 2017 Nov;39(1):678-687. doi: 10.1080/0886022X.2017.1363779.
7
Predictors of Hungry Bone Syndrome and Reintervention After Subtotal Versus Total Parathyroidectomy for Secondary Hyperparathyroidism in Dialysis Patients: A Single-Center Cohort.透析患者继发性甲状旁腺功能亢进行甲状旁腺次全切除术与全切除术后饥饿骨综合征及再次干预的预测因素:一项单中心队列研究
J Clin Med. 2025 Jul 12;14(14):4944. doi: 10.3390/jcm14144944.
8
Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis.肾性甲状旁腺功能亢进症行甲状旁腺全切术加自体移植与次全甲状旁腺切除术的系统评价和荟萃分析
Nephrology (Carlton). 2017 May;22(5):388-396. doi: 10.1111/nep.12801.
9
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.拟钙剂用于慢性肾病患者继发性甲状旁腺功能亢进的治疗
Cochrane Database Syst Rev. 2014;2014(12):CD006254. doi: 10.1002/14651858.CD006254.pub2. Epub 2014 Dec 9.
10
Parathyroidectomy for adults with primary hyperparathyroidism.甲状旁腺切除术治疗原发性甲状旁腺功能亢进症成人患者。
Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2.

本文引用的文献

1
Outcome of surgical parathyroidectomy for tertiary hyperparathyroidism in kidney transplant recipients: tertiary hyperparathyroidism should not be ignored, for the sake of precious allografts.肾移植受者甲状旁腺切除术治疗三发性甲状旁腺功能亢进症的结果:为了珍贵的同种异体移植物,三发性甲状旁腺功能亢进症不应被忽视。
Ren Fail. 2024 Dec;46(1):2333919. doi: 10.1080/0886022X.2024.2333919. Epub 2024 Apr 4.
2
Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease.甲状旁腺全切除术治疗终末期肾病继发甲状旁腺功能亢进症的优势。
Front Endocrinol (Lausanne). 2023 Nov 22;14:1191914. doi: 10.3389/fendo.2023.1191914. eCollection 2023.
3
Free triiodothyronine predicts the risk of developing diabetic kidney disease.
游离三碘甲状腺原氨酸可预测糖尿病肾脏疾病的发病风险。
BMC Nephrol. 2023 Oct 11;24(1):298. doi: 10.1186/s12882-023-03349-1.
4
Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease.磷酸盐与慢性肾脏病患者的冠状动脉疾病。
J Atheroscler Thromb. 2024 Jan 1;31(1):1-14. doi: 10.5551/jat.RV22012. Epub 2023 Sep 28.
5
Advances in the treatment of secondary and tertiary hyperparathyroidism.继发性和三发性甲状旁腺功能亢进症的治疗进展。
Front Endocrinol (Lausanne). 2022 Dec 6;13:1059828. doi: 10.3389/fendo.2022.1059828. eCollection 2022.
6
Role of the extracellular ATP/pyrophosphate metabolism cycle in vascular calcification.细胞外 ATP/焦磷酸盐代谢循环在血管钙化中的作用。
Purinergic Signal. 2023 Jun;19(2):345-352. doi: 10.1007/s11302-022-09867-1. Epub 2022 May 5.
7
Vascular Calcification: Key Roles of Phosphate and Pyrophosphate.血管钙化:磷酸盐和焦磷酸盐的关键作用。
Int J Mol Sci. 2021 Dec 17;22(24):13536. doi: 10.3390/ijms222413536.
8
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease.慢性肾脏病成人患者的继发性甲状旁腺功能亢进与不良健康结局
Clin Kidney J. 2021 Jan 20;14(10):2213-2220. doi: 10.1093/ckj/sfab006. eCollection 2021 Oct.
9
Thyroid hormone status in patients with impaired kidney function.肾功能受损患者的甲状腺激素状态。
Int Urol Nephrol. 2021 Nov;53(11):2349-2358. doi: 10.1007/s11255-021-02800-2. Epub 2021 Mar 8.
10
Inflammation: a putative link between phosphate metabolism and cardiovascular disease.炎症:磷酸盐代谢与心血管疾病之间的潜在联系。
Clin Sci (Lond). 2021 Jan 15;135(1):201-227. doi: 10.1042/CS20190895.